← Leaderboards
Lawrence S. Barak
Duke University
$6,045,982
Attributed
$11,919,265
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$11,919,265 · 8
By mechanism
UH3$6,363,247 · 1
UG3$3,588,880 · 1
R01$737,326 · 1
R21$428,806 · 1
P30$327,896 · 1
U18$241,500 · 1
Top collaborators
- Michael Jackson3 shared
- Marc G. Caron1 shared
- Jeffrey T Guptill1 shared
Most similar at Duke University
Same institution · by research overlap
- Anne Elizabeth West$11,899,497
- Marc G. Caron$32,189,154
- Laura M Bohn$20,645,026
- Charles A Gersbach$24,146,412
- Neil J. Freedman$13,528,793
Others in their field
Top investigators on “Arrestins”
- Jeffrey L Benovic · Thomas Jefferson University$25,781,930
- Vsevolod V. Gurevich · Sun Health Research Institute$20,501,681
- Bryan L Roth · Univ Of North Carolina Chapel Hill$18,071,242
- Robert J Lefkowitz · Duke University$17,365,480
- Marc G. Caron · Duke University$16,680,910
- Raymond B. Penn · Thomas Jefferson University$16,216,714
Research focus
ArrestinsReceptorAddictionBrainDopamineUnited StatesAmphetaminesMedicalSeriesPhosphorylationBeta-ArrestinCocainePharmacologyG-Protein-Coupled ReceptorsSignal TransductionRewardsLigandsLeadBiochemicalGreen Fluorescent ProteinsAddictive BehaviorPharmaceutical PreparationsMolecular TargetNeuraxis
Grant awards (14)
Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders$1,348,795
UH3 · FY2024 · DA
Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders$5,014,452
UH3 · FY2023 · DA
A novel functionally selective drug for the treatment of cocaine abuse by antagonism of the beta-arrestin signaling arm of the Ghrelin Receptor$241,500
U18 · FY2020 · DA · contact PI
Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders$3,588,880
UG3 · FY2019 · DA
Beta-arrestin Regulation of Ghrelin Signaling in Modulating Addictive Behavior$193,306
R21 · FY2015 · DA · contact PI
Beta-arrestin Regulation of Ghrelin Signaling in Modulating Addictive Behavior$235,500
R21 · FY2014 · DA · contact PI
Small Molecule Agonsists for the Neurotensin 1 Receptor$38,610
R03 · FY2011 · MH · contact PI
Science Plan$327,896
P30 · FY2010 · DA · contact PI
Small Molecule Agonsists for the Neurotensin 1 Receptor$39,000
R03 · FY2010 · MH · contact PI
Molecular fingerprinting of GPCR ligands in Cancer$77,000
R03 · FY2005 · CA
Molecular fingerprinting of GPCR ligands in Cancer$77,000
R03 · FY2004 · CA
MECHANISMS OF G PROTEIN COUPLED RECEPTOR REGULATION$253,076
R01 · FY2002 · HL
MECHANISMS OF G PROTEIN COUPLED RECEPTOR REGULATION$245,704
R01 · FY2001 · HL
MECHANISMS OF G PROTEIN COUPLED RECEPTOR REGULATION$238,546
R01 · FY2000 · HL